Negative association of time in range and urinary albumin excretion rate in patients with type 2 diabetes mellitus: a retrospective study of inpatients

被引:4
作者
Chai Sanbao
Wu Shanshan
Xin Sixu
Yuan Ning
Sun Jianbin
Zhang Xiaomei
Ji Linong
机构
[1] China
[2] Department of Endocrinology and Metabolism
[3] Beijing 102206
[4] Beijing 100050
[5] National Clinical Research Center of Digestive Diseases
[6] Capital Medical University Affiliated Beijing Friendship Hospital
[7] Peking University International Hospital
关键词
Time in range; Type; 2; diabetes; Urinary albumin excretion rate; Blood glucose;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
Background: Time in range (TIR) refers to the time an individual spends within their target glucose range, which now has been popularized as an important metric to classify glycemic management and also recognized as an important outcome of current diabetes therapies. This study aimed to investigate the association between TIR and the severity of the urinary albumin excretion rate (UAER) in patients with type 2 diabetes mellitus (T2DM).Methods: We retrospectively analyzed the data of 1014 inpatients with T2DM at the Department of Endocrinology and Metabolism of Peking University International Hospital, China. TIR was defined as the percentage of blood glucose within the target range of 3.90-10.00 mmol/L. Urine samples for assessment of UAER were collected for 3 consecutive days from the start of hospitalization.Results: The TIR values for patients with normal urine levels of albumin, microalbuminuria, and macroalbuminuria were 70% ± 20%, 50% ± 20%, and 30% ± 20%, respectively (allP < 0.001). The patients were stratified according to quartiles of TIR as follows: quartile (Q) 1, <55%; Q2, 55%-72%; Q3, 73%-83%; and Q4, >83%. The incidences of microalbuminuria in Q1, Q2, Q3, and Q4 were 41.1%, 21.6%, 7.1%, and 5.5% (allP < 0.001), respectively. The respective incidences of macroalbuminuria were 24.2%, 1.1%, 1.4%, and 0% (allP < 0.001). In multinomial logistic regression analyses, TIR was significantly correlated with microalbuminuria (odds ratio [OR] 0.58, 95% confidence interval [CI]: 0.52-0.65,P < 0.001) and macroalbuminuria (OR 0.26, 95% CI: 0.18-0.38,P < 0.001) after adjusting for age, sex, body mass index, diabetes duration, systolic blood pressure, and levels of triglycerides, glycosylated hemoglobin A1c, and creatinine.Conclusion: The proportion of blood glucose in TIR is closely related to the severity of UAER in patients with T2DM.
引用
收藏
页码:1052 / 1056
页数:5
相关论文
共 16 条
  • [1] Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes
    Lu, Jingyi
    Ma, Xiaojing
    Shen, Yun
    Wu, Qiang
    Wang, Ren
    Zhang, Lei
    Mo, Yifei
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Vigersky, Robert A.
    Jia, Weiping
    Zhou, Jian
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (02) : 72 - 78
  • [2] Positioning time in range in diabetes management
    Advani, Andrew
    [J]. DIABETOLOGIA, 2020, 63 (02) : 242 - 252
  • [3] Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Ying, Lingwen
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Zhou, Jian
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 753 - 759
  • [4] Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
    Beck, Roy W.
    Bergenstal, Richard M.
    Riddlesworth, Tonya D.
    Kollman, Craig
    Li, Zhaomian
    Brown, Adam S.
    Close, Kelly L.
    [J]. DIABETES CARE, 2019, 42 (03) : 400 - 405
  • [5] The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats[J] . Yang Junpeng,Zhao Zhigang,Yuan Huijuan,Ma Xiangxiang,Li Yakun,Wang Huimeng,Ma Xiaojun,Qin Guijun.Biochemical and Biophysical Research Communications . 2018 (1)
  • [6] Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
    Lu, Jingyi
    Ma, Xiaojing
    Zhou, Jian
    Zhang, Lei
    Mo, Yifei
    Ying, Lingwen
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Vigersky, Robert A.
    Jia, Weiping
    [J]. DIABETES CARE, 2018, 41 (11) : 2370 - 2376
  • [7] Going Beyond HbA1C to Understand the Benefits of Advanced Diabetes Therapies[J] . Vigersky Robert A.Journal of diabetes . 2018 (1)
  • [8] Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes[J] . Runge Ava S,Kennedy Lynn,Brown Adam S,Dove Abigail E,Levine Brian J,Koontz Sophie P,Iyengar Varun S,Odeh Sarah A,Close Kelly L,Hirsch Irl B,Wood Richard.Clinical diabetes : a publication of the American Diabetes Association . 2018 (2)
  • [9] The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading
    Beck, Roy W.
    Connor, Crystal G.
    Mullen, Deborah M.
    Wesley, David M.
    Bergenstal, Richard M.
    [J]. DIABETES CARE, 2017, 40 (08) : 994 - 999
  • [10] IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040[J] . K. Ogurtsova,J.D. da Rocha Fernandes,Y. Huang,U. Linnenkamp,L. Guariguata,N.H. Cho,D. Cavan,J.E. Shaw,L.E. Makaroff.Diabetes Research and Clinical Practice . 2017